May 8 (SeeNews) - Romanian drug group A&D Pharma's unaudited consolidated sales fell by an annual 11% to 113.2 million euro ($151 million) in the first quarter of the year due to the steep depreciation of local leu currency, the company's owner, Dutch-based A&D Pharma Holdings N.V., said on Friday.